Pharma Reaserch Products Co Ltd (214450)

Currency in KRW
664,000
+56,000(+9.21%)
Closed·
214450 Scorecard
Full Analysis
Has raised its dividend for 5 consecutive years
Unusual trading volume
Trading near 52-week High
214450 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
578,000678,000
52 wk Range
165,300678,000
Key Statistics
Bid/Ask
664,000.00 / 665,000.00
Prev. Close
608,000
Open
605,000
Day's Range
578,000-678,000
52 wk Range
165,300-678,000
Volume
315.37K
Average Volume (3m)
127.14K
1-Year Change
286.72%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
214450 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
657,000
Downside
-1.05%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Pharma Reaserch Products Co Ltd Company Profile

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults through the physical restoration; Rejuran HB plus which is used for temporary improvement of adult's crow's feet wrinkles; Rejuvenex injection, a tissue regeneration activator that regenerates connective tissues, including ligament, tendon, skin, etc.; and Rejuvenex cream, which treats the wound through rapid tissue regeneration. It also provides REJURAN, a medical device for face (especially eye, perioral area), neck, Décolleté, hands, etc; CLEVIEL prime plus and contour plus with lidocaine medical devices; D+CELL 350 TRA I; and REJURAN moisturizer for daily skin protection, as well as REJUVENEX SCULPT V; REJURAN concentrate for sensitive and aged skin; REJURAN healing eye gel and mask; REJURAN sunscreen that protects skin from UV rays; and REJURAN recover soothing mask. In addition, the company offers D+CELL 350 TRA concentrated rejuvenation cream, intensive repair serum, activating facial toner, high potency eye lift, moisture balancer, mask, hair, cream, and hydro products; REJURAN tone-up booster; REJURAN FORTE; and CONJURAN medical devices. Further, it offers functional foods; and engages in the development of software and consulting businesses. The company was formerly known as Pharma Research Products Co., Ltd. and changed its name to PharmaResearch Co., Ltd. in April 2021. PharmaResearch Co., Ltd. was founded in 1993 and is headquartered in Gangneung-si, South Korea.

Employees
409

Compare 214450 to Peers and Sector

Metrics to compare
214450
Peers
Sector
Relationship
P/E Ratio
62.2x6.2x−0.5x
PEG Ratio
1.420.050.00
Price/Book
12.2x1.8x2.6x
Price / LTM Sales
17.6x7.5x3.3x
Upside (Analyst Target)
5.4%43.1%43.5%
Fair Value Upside
Unlock14.6%6.8%Unlock

Analyst Ratings

9 Buy
1 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 657,000
(-1.05% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 10,730.38%
Dividend Yield
0.17%
Industry Median 0.93%
Annualised payout
1,100.00
Paid annually
5-Years Growth
+29.67%
Growth Streak

Earnings

Latest Release
Aug 08, 2025
EPS / Forecast
-- / 2,607.00
Revenue / Forecast
132.50B / 127.13B
EPS Revisions
Last 90 days

214450 Income Statement

People Also Watch

30,400
009830
+0.66%
135,400
267250
-0.95%
66,400
034020
+1.53%
230,000.00
278470
+4.78%
101,900
000270
+0.10%

FAQ

What Stock Exchange Does Pharma Reaserch Products Trade On?

Pharma Reaserch Products is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Pharma Reaserch Products?

The stock symbol for Pharma Reaserch Products is "214450."

What Is the Pharma Reaserch Products Market Cap?

As of today, Pharma Reaserch Products market cap is 6.90T.

What Is Pharma Reaserch Products's Earnings Per Share (TTM)?

The Pharma Reaserch Products EPS (TTM) is 10,730.38.

When Is the Next Pharma Reaserch Products Earnings Date?

Pharma Reaserch Products will release its next earnings report on 17 Nov 2025.

From a Technical Analysis Perspective, Is 214450 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Pharma Reaserch Products Stock Split?

Pharma Reaserch Products has split 0 times.

How Many Employees Does Pharma Reaserch Products Have?

Pharma Reaserch Products has 409 employees.

What is the current trading status of Pharma Reaserch Products (214450)?

As of 09 Aug 2025, Pharma Reaserch Products (214450) is trading at a price of 664,000.00, with a previous close of 608,000.00. The stock has fluctuated within a day range of 578,000.00 to 678,000.00, while its 52-week range spans from 165,300.00 to 678,000.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.